{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:10:14Z","timestamp":1794917414733,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Women are predisposed to develop intolerance to cancer chemotherapy. Sarcopenia and chemotherapy are mutually related. Women are generally intolerable to chemotherapeutics such as 5-fluorouracil. Although adjuvant oxaliplatin-based chemotherapy, e.g. CAPOX is commonly used to treat colorectal cancer, its effects on patients in terms of sarcopenia and sex remain unknown. We investigated sex disparities in the impacts of CAPOX on body composition in this study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a prospective study on diagnostic metrics used for sarcopenia in colorectal cancer patients receiving adjuvant CAPOX. Evaluations of the nutritional status by the Mini-Nutritional Assessment (MNA), gait speed, grip strength, skeletal muscle mass, fat mass, and bone mineral content using a body composition analyzer were performed in the first, fourth, and eighth cycles of CAPOX (first, second, and third measurements, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 80 eligible patients, 61 completed four CAPOX cycles. The median differences in MNA, gait, grip strength, muscle mass, fat mass, and bone mineral content between the first and second measurements for men (<jats:italic>n<\/jats:italic>\u2009=\u200935) and women (<jats:italic>n<\/jats:italic>\u2009=\u200926) were +\u200910.5% and +\u20092.9% (<jats:italic>p<\/jats:italic>\u2009=\u20090.067), +\u20094.5% and \u2212\u20092.6% (<jats:italic>p<\/jats:italic>\u2009=\u20090.16), +\u20091.8% and +\u20092.8% (<jats:italic>p<\/jats:italic>\u2009=\u20090.66), +\u20092.7% and +\u20091.3% (<jats:italic>p<\/jats:italic>\u2009=\u20090.021), +\u20094.5% and +\u20093.5% (<jats:italic>p<\/jats:italic>\u2009=\u20090.59), and +\u20093.3% and +\u20090.0% (<jats:italic>p<\/jats:italic>\u2009=\u20090.006), There were no sex differences in comparisons of the above metrics between the first and third measurements in 34 patients who completed eight CAPOX cycles (19 wen and 15 women).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Early cycles of adjuvant CAPOX may have a negative impact on the postoperative recovery of several metrics for diagnosing sarcopenia in women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-024-06013-9","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T12:01:48Z","timestamp":1729944108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sex differences in recovery from postoperative sarcopenia during adjuvant CAPOX therapy for colorectal cancer"],"prefix":"10.1007","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7891-5986","authenticated-orcid":false,"given":"Hiroaki","family":"Nozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Yakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenobu","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Murono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Shinagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Akishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,26]]},"reference":[{"key":"6013_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jgo.2013.04.001","volume":"4","author":"AA Aaldriks","year":"2013","unstructured":"Aaldriks AA, van der Geest LG, Giltay EJ et al (2013) Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol 4:218\u2013226. https:\/\/doi.org\/10.1016\/j.jgo.2013.04.001","journal-title":"J Geriatr Oncol"},{"key":"6013_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.clcc.2018.12.006","volume":"18","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O (2019) Impact of sex on Chemotherapy toxicity and efficacy among patients with metastatic colorectal Cancer: pooled analysis of 5 randomized trials. Clin Colorectal Cancer 18:110\u2013115e2. https:\/\/doi.org\/10.1016\/j.clcc.2018.12.006","journal-title":"Clin Colorectal Cancer"},{"key":"6013_CR3","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343\u20132351. https:\/\/doi.org\/10.1056\/NEJMoa032709","journal-title":"N Engl J Med"},{"key":"6013_CR4","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/S1470-2045(20)30527-1","volume":"21","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Meyerhardt J, Iveson T et al (2020) Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol 21:1620\u20131629. https:\/\/doi.org\/10.1016\/S1470-2045(20)30527-1","journal-title":"Lancet Oncol"},{"key":"6013_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1186\/s12885-019-6086-2","volume":"19","author":"S Antoun","year":"2019","unstructured":"Antoun S, Bayar MA, Dyevre V et al (2019) No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer. BMC Cancer 19:847. https:\/\/doi.org\/10.1186\/s12885-019-6086-2","journal-title":"BMC Cancer"},{"key":"6013_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R et al (2020) Localised colon cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31:1291\u20131305. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.022","journal-title":"Ann Oncol"},{"key":"6013_CR7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.clnu.2022.03.016","volume":"41","author":"L Arribas","year":"2022","unstructured":"Arribas L, Sabat\u00e9-Llobera A, Domingo MC et al (2022) Assessing dynamic change in muscle during treatment of patients with cancer: Precision testing standards. Clin Nutr 41:1059\u20131065. https:\/\/doi.org\/10.1016\/j.clnu.2022.03.016","journal-title":"Clin Nutr"},{"key":"6013_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","volume":"34","author":"S Blauwhoff-Bsukemolen","year":"2016","unstructured":"Blauwhoff-Bsukemolen S, Versteeg KS, de van der Schueren MA et al (2016) Loss of muscle Mass during Chemotherapy is predictive for poor survival of patients with metastatic colorectal Cancer. J Clin Oncol 34:1339\u20131344. https:\/\/doi.org\/10.1200\/JCO.2015.63.6043","journal-title":"J Clin Oncol"},{"key":"6013_CR9","volume-title":"TNM classification of malignant tumors","author":"JD Brierley","year":"2016","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2016) TNM classification of malignant tumors, 8th edn. Wiley-Blackwell, Oxford","edition":"8"},{"key":"6013_CR10","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1158\/1078-0432.CCR-06-1382","volume":"12","author":"JE Brown","year":"2006","unstructured":"Brown JE, Ellis SP, Silcocks P et al (2006) Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma. Clin Cancer Res 12:6480\u20136486. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1382","journal-title":"Clin Cancer Res"},{"key":"6013_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.nut.2018.11.028","volume":"62","author":"GD Ceniccola","year":"2019","unstructured":"Ceniccola GD, Castro MG, Piovacari SMF et al (2019) Current technologies in body composition assessment: advantages and disadvantages. Nutrition 62:25\u201331. https:\/\/doi.org\/10.1016\/j.nut.2018.11.028","journal-title":"Nutrition"},{"key":"6013_CR12","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1002\/cncr.30950","volume":"123","author":"EM Cespedes Feliciano","year":"2017","unstructured":"Cespedes Feliciano EM, Lee VS, Prado CM et al (2017) Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: the C-SCANS study. Cancer 123:4868\u20134877. https:\/\/doi.org\/10.1002\/cncr.30950","journal-title":"Cancer"},{"key":"6013_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/cncr.20878","volume":"103","author":"K Chansky","year":"2005","unstructured":"Chansky K, Benedetti J, Macdonald JS (2005) Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma. Cancer 103:1165\u20131171. https:\/\/doi.org\/10.1002\/cncr.20878","journal-title":"Cancer"},{"key":"6013_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P et al (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and treatment. Am Med Dir Assoc 21:300\u2013307e2. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012","journal-title":"Am Med Dir Assoc"},{"key":"6013_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older people. Age Ageing 39:412\u2013423. https:\/\/doi.org\/10.1093\/ageing\/afq034","journal-title":"Age Ageing"},{"key":"6013_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1017\/S136898000800195X","volume":"12","author":"M Cuervo","year":"2009","unstructured":"Cuervo M, Garc\u00eda A, Ansorena D et al (2009) Nutritional assessment interpretation on 22007 Spanish community-dwelling elders through the Mini Nutritional Assessment test. Public Health Nutr 12:82\u201390. https:\/\/doi.org\/10.1017\/S136898000800195X","journal-title":"Public Health Nutr"},{"key":"6013_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00228-022-03298-y","volume":"78","author":"S De Francia","year":"2022","unstructured":"De Francia S, Berchialla P, Armando T et al (2022) Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities. Eur J Clin Pharmcol 78:1029\u20131038. https:\/\/doi.org\/10.1007\/s00228-022-03298-y","journal-title":"Eur J Clin Pharmcol"},{"key":"6013_CR18","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA et al (2019) Colorectal cancer. Lancet 394:1467\u20131480. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0","journal-title":"Lancet"},{"key":"6013_CR19","doi-asserted-by":"publisher","unstructured":"Deurenberg P (1996) Limitations of the bioelectrical impedance method for the assessment of body fat in severe obesity. Am J Clin Nutr 64. https:\/\/doi.org\/10.1093\/ajcn\/64.3.449S. 449S-452S","DOI":"10.1093\/ajcn\/64.3.449S"},{"key":"6013_CR20","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1016\/j.clnu.2020.02.017","volume":"39","author":"A Dolly","year":"2020","unstructured":"Dolly A, Lecomte T, Bouch\u00e9 O et al (2020) Concurrent losses of skeletal muscle mass, adipose tissue and bone mineral density during bevacizumab \/ cytotoxic chemotherapy treatment for metastatic colorectal cancer. Clin Nutr 39:3319\u20133330. https:\/\/doi.org\/10.1016\/j.clnu.2020.02.017","journal-title":"Clin Nutr"},{"key":"6013_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/ALN.0000000000000874","volume":"124","author":"H Farhan","year":"2016","unstructured":"Farhan H, Moreno-Duarte I, Latronico N et al (2016) Acquired muscle weakness in the Surgical Intensive Care Unit: Nosology, Epidemiology, diagnosis, and Prevention. Anesthesiology 124:207\u2013234. https:\/\/doi.org\/10.1097\/ALN.0000000000000874","journal-title":"Anesthesiology"},{"key":"6013_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","volume":"378","author":"A Grothey","year":"2018","unstructured":"Grothey A, Sobrero AF, Shields AF et al (2018) Duration of adjuvant chemotherapy for stage III colon cancer. N Engl J Med 378:1177\u20131188. https:\/\/doi.org\/10.1056\/NEJMoa1713709","journal-title":"N Engl J Med"},{"key":"6013_CR22","first-page":"466","volume":"10","author":"Y Guigoz","year":"2006","unstructured":"Guigoz Y (2006) The Mini Nutritional Assessment (MNA) review of the literature\u2014what does it tell us? J Nutr Health Aging 10:466\u2013485 discussion 85\u201387","journal-title":"J Nutr Health Aging"},{"key":"6013_CR24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ctrv.2012.02.008","volume":"38","author":"P Hadji","year":"2012","unstructured":"Hadji P, Gnant M, Body JJ et al (2012) Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention? Cancer Treat Rev 38:798\u2013806. https:\/\/doi.org\/10.1016\/j.ctrv.2012.02.008","journal-title":"Cancer Treat Rev"},{"key":"6013_CR25","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","volume":"29","author":"DG Haller","year":"2011","unstructured":"Haller DG, Tabernero J, Maroun J et al (2011) Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 29:1465\u20131471. https:\/\/doi.org\/10.1200\/JCO.2010.33.6297","journal-title":"J Clin Oncol"},{"key":"6013_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.clnesp.2021.08.010","volume":"45","author":"K Hamilton-James","year":"2021","unstructured":"Hamilton-James K, Collet TH, Pichard C et al (2021) Precision and accuracy of bioelectrical impedance analysis devices in supine versus standing position with or without retractable handle in caucasian subjects. Clin Nutr ESPEN 45:267\u2013274. https:\/\/doi.org\/10.1016\/j.clnesp.2021.08.010","journal-title":"Clin Nutr ESPEN"},{"key":"6013_CR27","doi-asserted-by":"publisher","first-page":"afac234","DOI":"10.1093\/ageing\/afac234","volume":"51","author":"EJ Hardy","year":"2022","unstructured":"Hardy EJ, Hatt J, Doleman B et al (2022) Post-operative electrical muscle stimulation attenuates loss of muscle mass and function following major abdominal surgery in older adults: a split body randomised control trial. Age Ageing 51:afac234. https:\/\/doi.org\/10.1093\/ageing\/afac234","journal-title":"Age Ageing"},{"key":"6013_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, Muro K, Saito Y et al (2020) Japanese Society for Cancer of the Colon and rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1\u201342. https:\/\/doi.org\/10.1007\/s10147-019-01485-z","journal-title":"Int J Clin Oncol"},{"key":"6013_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/ejcn.2014.203","volume":"69","author":"EB Haverkort","year":"2015","unstructured":"Haverkort EB, Reijven PL, Binnekade JM et al (2015) Bioelectrical impedance analysis to estimate body composition in surgical and oncological patients: a systematic review. Eur J Clin Nutr 69:3\u201313. https:\/\/doi.org\/10.1038\/ejcn.2014.203","journal-title":"Eur J Clin Nutr"},{"key":"6013_CR30","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1007\/s00268-019-05054-3","volume":"43","author":"JJ Hopkins","year":"2019","unstructured":"Hopkins JJ, Reif R, Bigam D et al (2019) Change in skeletal muscle following resection of Stage I\u2013III colorectal Cancer is predictive of poor survival: a Cohort Study. World J Surg 43:2518\u20132526. https:\/\/doi.org\/10.1007\/s00268-019-05054-3","journal-title":"World J Surg"},{"key":"6013_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00520-014-2418-6","volume":"23","author":"HW Jung","year":"2015","unstructured":"Jung HW, Kim JW, Kim JY et al (2015) Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer 23:687\u2013694. https:\/\/doi.org\/10.1007\/s00520-014-2418-6","journal-title":"Support Care Cancer"},{"key":"6013_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/jcsm.12337","volume":"9","author":"SA Kurk","year":"2018","unstructured":"Kurk SA, Peeters PHM, Dorresteijn B et al (2018) Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients. J Cachexia Sarcopenia Muscle 9:909\u2013919. https:\/\/doi.org\/10.1002\/jcsm.12337","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"6013_CR33","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jcsm.12436","volume":"10","author":"S Kurk","year":"2019","unstructured":"Kurk S, Peeters P, Stellato R et al (2019) Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients. J Cachexia Sarcopenia Muscle 10:803\u2013813. https:\/\/doi.org\/10.1002\/jcsm.12436","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"6013_CR34","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.clnu.2004.06.004","volume":"23","author":"UG Kyle","year":"2004","unstructured":"Kyle UG, Bosaeus I, De Lorenzo AD et al (2004) Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr 23:1226\u20131243. https:\/\/doi.org\/10.1016\/j.clnu.2004.06.004","journal-title":"Clin Nutr"},{"key":"6013_CR35","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1200\/JCO.2006.08.6652","volume":"25","author":"SR Land","year":"2007","unstructured":"Land SR, Kopec JA, Cecchini RS et al (2007) Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol 25:2205\u20132211. https:\/\/doi.org\/10.1200\/JCO.2006.08.6652","journal-title":"J Clin Oncol"},{"key":"6013_CR36","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1200\/JCO.2007.15.6687","volume":"26","author":"JA Meyerhardt","year":"2008","unstructured":"Meyerhardt JA, Niedzwiecki D, Hollis D et al (2008) Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 26:4109\u20134115. https:\/\/doi.org\/10.1200\/JCO.2007.15.6687","journal-title":"J Clin Oncol"},{"key":"6013_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jpainsymman.2016.12.342","volume":"54","author":"C Miaskowski","year":"2017","unstructured":"Miaskowski C, Mastick J, Paul SM et al (2017) Chemotherapy-Induced Neuropathy in Cancer survivors. J Pain Symptom Manage 54:204\u2013218e2. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.12.342","journal-title":"J Pain Symptom Manage"},{"key":"6013_CR38","doi-asserted-by":"publisher","first-page":"e0129742","DOI":"10.1371\/journal.pone.0129742","volume":"10","author":"Y Miyamoto","year":"2015","unstructured":"Miyamoto Y, Baba Y, Sakamoto Y et al (2015) Negative Impact of Skeletal Muscle Loss after systemic chemotherapy in patients with unresectable colorectal Cancer. PLoS ONE 10:e0129742. https:\/\/doi.org\/10.1371\/journal.pone.0129742","journal-title":"PLoS ONE"},{"key":"6013_CR41","unstructured":"National Comprehensive Cancer Network (2024a) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Rectal Cancer Version 2.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/rectal.pdf. Accessed 14 June 2024"},{"key":"6013_CR40","unstructured":"National Comprehensive Cancer Network (2024b) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Colon Cancer Version 3.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf. Accessed 14 June 2024"},{"key":"6013_CR39","unstructured":"National Cancer Institute (2017) Common Terminology Criteria for Adverse Events (CTCAE) v5.0. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed 14 June 2024"},{"key":"6013_CR42","doi-asserted-by":"publisher","first-page":"6957","DOI":"10.1007\/s00520-021-06231-8","volume":"29","author":"Y Nisha","year":"2021","unstructured":"Nisha Y, Dubashi B, Bobby Z et al (2021) Effect of cytotoxic chemotherapy on bone health among breast cancer patients. Does it require intervention? Support Care Cancer 29:6957\u20136972. https:\/\/doi.org\/10.1007\/s00520-021-06231-8","journal-title":"Support Care Cancer"},{"key":"6013_CR43","doi-asserted-by":"publisher","first-page":"e14863","DOI":"10.1111\/ijcp.14863","volume":"75","author":"H Nozawa","year":"2021","unstructured":"Nozawa H, Kawai K, Sasaki K et al (2021) Women are predisposed to early dose-limiting toxicities during adjuvant CAPOX for colorectal cancer. Int J Clin Pract 75:e14863. https:\/\/doi.org\/10.1111\/ijcp.14863","journal-title":"Int J Clin Pract"},{"key":"6013_CR44","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1007\/s00520-020-05477-y","volume":"28","author":"U Oflazoglu","year":"2020","unstructured":"Oflazoglu U, Alacacioglu A, Varol U et al (2020) The role of inflammation in adjuvant chemotherapy-induced Sarcopenia (Izmir Oncology Group (IZOG) study). Support Care Cancer 28:3965\u20133977. https:\/\/doi.org\/10.1007\/s00520-020-05477-y","journal-title":"Support Care Cancer"},{"key":"6013_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.critrevonc.2006.01.001","volume":"59","author":"LM Pasetto","year":"2006","unstructured":"Pasetto LM, D\u2019Andrea MR, Rossi E et al (2006) Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol 59:159\u2013168. https:\/\/doi.org\/10.1016\/j.critrevonc.2006.01.001","journal-title":"Crit Rev Oncol Hematol"},{"key":"6013_CR46","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","volume":"13","author":"CMM Prado","year":"2007","unstructured":"Prado CMM, Baracos V, McCargar LJ et al (2007) Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13:3264\u20133268. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-3067","journal-title":"Clin Cancer Res"},{"key":"6013_CR47","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1200\/JCO.2015.60.9107","volume":"33","author":"H Schmoll","year":"2015","unstructured":"Schmoll H, Tabernero J, Maroun J et al (2015) Capecitabine plus oxaliplatin compared with fluorouracil\/folinic acid as adjuvant therapy for stage III colon cancer: final results of the NO16968 randomized controlled phase III trial. J Clin Oncol 33:3733\u20133740. https:\/\/doi.org\/10.1200\/JCO.2015.60.9107","journal-title":"J Clin Oncol"},{"key":"6013_CR48","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1200\/JCO.2002.20.6.1491","volume":"20","author":"JA Sloan","year":"2002","unstructured":"Sloan JA, Goldberg RM, Sargent DJ et al (2002) Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol 20:1491\u20131498. https:\/\/doi.org\/10.1200\/JCO.2002.20.6.1491","journal-title":"J Clin Oncol"},{"key":"6013_CR49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ (2009) Mechanisms of cancer cachexia. Physiol Rev 89:381\u2013410. https:\/\/doi.org\/10.1152\/physrev.00016.2008","journal-title":"Physiol Rev"},{"key":"6013_CR50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/bjs.1800830320","volume":"83","author":"O Vinge","year":"1996","unstructured":"Vinge O, Edvardsen L, Jensen F et al (1996) Effect of transcutaneous electrical muscle stimulation on postoperative muscle mass and protein synthesis. Br J Surg 83:360\u2013363. https:\/\/doi.org\/10.1002\/bjs.1800830320","journal-title":"Br J Surg"},{"key":"6013_CR51","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/jnci\/djaa124","volume":"113","author":"AD Wagner","year":"2021","unstructured":"Wagner AD, Grothey A, Andre T et al (2021) Sex and adverse events of adjuvant chemotherapy in Colon cancer: an analysis of 34 640 patients in the ACCENT database. J Natl Cancer Inst 113:400\u2013407. https:\/\/doi.org\/10.1093\/jnci\/djaa124","journal-title":"J Natl Cancer Inst"},{"key":"6013_CR52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00280-017-3487-2","volume":"81","author":"GR William","year":"2018","unstructured":"William GR, Deal AM, Shachar SS et al (2018) The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer. Cancer Chemother Pharmacol 81:413\u2013417. https:\/\/doi.org\/10.1007\/s00280-017-3487-2","journal-title":"Cancer Chemother Pharmacol"},{"key":"6013_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ctarc.2016.09.002","volume":"9","author":"RM Winkels","year":"2016","unstructured":"Winkels RM, Snetselaara T, Adriaans A et al (2016) Changes in body weight in patients with colorectal cancer treated with surgery and adjuvant chemotherapy: an observational study. Cancer Treat Res Commun 9:111\u2013115. https:\/\/doi.org\/10.1016\/j.ctarc.2016.09.002","journal-title":"Cancer Treat Res Commun"},{"key":"6013_CR54","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/jcb.20889","volume":"99","author":"CJ Xian","year":"2006","unstructured":"Xian CJ, Cool JC, Pyragius T et al (2006) Damage and recovery of the bone growth mechanism in young rats following 5-fluorouracil acute chemotherapy. J Cell Biochem 99:1688\u20131704. https:\/\/doi.org\/10.1002\/jcb.20889","journal-title":"J Cell Biochem"},{"key":"6013_CR55","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10120-014-0365-z","volume":"18","author":"Y Yamaoka","year":"2014","unstructured":"Yamaoka Y, Fujitani K, Tsujinaka T et al (2014) Skeletal muscle loss after total gastrectomy, exacerbated by adjuvant chemotherapy. Gastric Cancer 18:382\u2013389. https:\/\/doi.org\/10.1007\/s10120-014-0365-z","journal-title":"Gastric Cancer"},{"key":"6013_CR56","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00280-019-03841-2","volume":"84","author":"O Yigit","year":"2019","unstructured":"Yigit O, Kulak Kayikci ME, Temucin CM et al (2019) Electrophysiologic evaluation of facial nerve functions after oxaliplatin treatment. Cancer Chemother Pharmacol 84:513\u2013520. https:\/\/doi.org\/10.1007\/s00280-019-03841-2","journal-title":"Cancer Chemother Pharmacol"},{"key":"6013_CR57","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.annonc.2021.08.1752","volume":"32","author":"T Yoshino","year":"2021","unstructured":"Yoshino T, Argil\u00e9s G, Oki E et al (2021) Pan-asian adapted ESMO Clinical Practice guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer. Ann Oncol 32:1496\u20131510. https:\/\/doi.org\/10.1016\/j.annonc.2021.08.1752","journal-title":"Ann Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-06013-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-06013-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-06013-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:07:04Z","timestamp":1730812024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-06013-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["6013"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-06013-9","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,26]]},"assertion":[{"value":"15 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Tokyo (Reference No:2021363NI).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"478"}}